Conduct problems and hurtful and uncaring behaviors in children as young as 6 are harbingers of violent and nonviolent criminal convictions in young adulthood. Medscape Medical News
Read >

For the first time, deep brain stimulation has been used to treat patients with severe refractory anorexia, with promising results. Medscape Medical News
Read >

Retinal blood vessel changes may serve as biomarkers for amyloid plaque in the brain, which in turn may signal early stages of Alzheimer’s disease, new research shows. Medscape Medical News
Read >

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat,…
Read >

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat,…
Read >

  Second-Hand Smoke Negatively Affects Mental Health While nicotine from smoking is usually associated with physical health, a new study has shown that inhaling this drug, even from secondhand smoke (SHS), affects one’s mental health. Mark Hamer, PhD, of University College London, and colleagues, observed 5,560 nonsmoking adults (average age=49.8 years) and 2,595 active smokers…
Read >

L-methylfolate Effective in the Treatment of a MDD Pharmacotherapy for major depressive disorder (MDD) includes monotherapy with either a selective serotonin reuptake inhibitor (SSRI) or a selective norepinephrine reuptake inhibitor (SNRI). SSRI/SNRI combination therapy has also proven to be effective. Recent research has been conducted to determined the efficacy of l-methylfolate, a prescription medical food…
Read >

Children who Lost a Parent to Suicide at a Higher Risk for Suicide It is estimated that 7, 000–12, 000 children lose a parent to suicide annually in the United States. According to a study led by Johns Hopkins Children’s Center, children of parents who have committed suicide have a significantly greater risk for hospitalization…
Read >

  Researchers Analyze Prescription Rates for Psychiatric Medications Tami K. Mark, PhD, and colleagues analyzed data from the 2005 National Disease and Therapeutic Index (NDTI) in order to examine which disease states psychiatric medications were being prescribed for. The NDTI is a continuing survey of over 4,000 office-based United States-based physicians. These physicians provide quarterly…
Read >

High Rates of Psychiatric Disorders Found in the Wives of Deployed Soldiers Active military deployment can be a stressful period for both the family member on active deployment as well as family members at home waiting for a safe return. The mental health status of the wives of active military personnel, including those soldiers that…
Read >

Number of Patients Receiving Multiple Medications for a Single Condition is on the Rise The number of patients receiving multiple medications for a single condition has recently been on the rise. Although polypharmacy  can be an effective weapon in a physician’s arsenal, one must be aware of the potential for over-reliance, drug-drug interactions (DDIs), and…
Read >

Psychiatric Dispatches Print Friendly    FDA Approves Aripiprazole for Treatment of Irritability Associated with Autism in Pediatric Patients The United States Food and Drug Administration approved aripiprazole (Abilify, Otsuka Pharmaceutical Group) for the treatment of irritability associated with autism in pediatric patients. The recommended initial dose for this indication is 2 mg/day. The target and…
Read >

  Late-life Depression: Potential Prevalance Rates and Treatment Options Late-life depression is a cause of concern for families, caregivers, and mental health professionals. However, because most elderly patients visit their primary care physicians (PCPs) about their depression, and not mental health specialists, it is imperative that PCPs be aware of both the prevalence of depression…
Read >

Omega-3 Augmentation of Sertraline in Depressed Patients with Coronary Heart Disease Proves Ineffective Studies have shown that patients who are depressed but otherwise medically well benefit from omega-3 fatty acids as augmentation to antidepressant treatment. However, according to a recent study conducted between May 2005 and December 2008 by Robert M. Carney, PhD, at Washington…
Read >

Binge and At-Risk Drinking Behavior Prevalent in Older Adult Population Relative to the high prevalence of alcohol use and abuse among young adults, middle-aged adults and the elderly as a population have not been shown to consume alcohol in excess or suffer from alcohol abuse in large numbers. However, studies have shown that alcohol use…
Read >

  FDA Approves Asenapine for Acute Treatment of Schizophrenia and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features The United States Food and Drug Administration approved asenapine (Saphris, Schering-Plough) for the acute treatment of schizophrenia in adults and manic or mixed episodes of bipolar I disorder with or without psychotic…
Read >

Psychiatric Dispatches Print Friendly  Primary Psychiatry. 2009;16(8):17-18   Medication and Improved Test Scores in ADHD Recent prevalence rates suggest that ~7.8% (4.4 million) of American children have been diagnosed with attention-deficit/hyperactivity disorder (ADHD), with ~56% of affected children receiving ADHD medication. Richard Scheffler, PhD, from the University of California, Berkeley, and colleagues, recently published the…
Read >

Psychiatric Dispatches Print Friendly  Primary Psychiatry. 2009;16(7):16-18   Risk of Psychotic Symptom Development Increased for School-aged Children Who Experience Peer Victimization In prior studies, psychotic symptoms (ie, hallucinations, delusions, and other thought disorders) in adults have been linked to past childhood experience of trauma, including abuse. Although studies have shown that both children and adults…
Read >

Psychiatric Dispatches Print Friendly  Primary Psychiatry. 2009;16(6):12-14   FDA Approves Lamotrigine Orally Disintegrating Tablets for Bipolar I Disorder The United States Food and Drug Administration approved lamotrigine orally disintegrating tables (Lamictal ODT, GlaxoSmithKline) for the treatment of bipolar I disorder in patients >18 years of age. Unlike previous versions of lamotrigine, lamotrigine ODT disintegrates on…
Read >

  Guideline-based Occupational Care for Workers with Mental Disorders Effective in Reducing Treatment Cost According to the National Institute of Mental Health, mental health disorders are the leading cause of disability in the United States and Canada for people 15–44 years of age. Globally, mental illness accounts for >15% of the burden of disease in…
Read >

Telephone Survey Finds Portion of Depressed and Anxious Patients Remain Ill Years After Treatment is Initiated Although effective treatments are available, a large portion of patients suffering from depressive and anxiety disorders can remain ill for many years after initial diagnosis. Alexander S. Young, MD, MSPH, and colleagues from the University of California, Los Angeles,…
Read >

FDA Approves Milnacipran HCI for the Management of Fibromyalgia The United States Food and Drug Administration approved milnacipran HCl (Savella, Forest Laboratories) for the treatment of fibromyalgia. It will be available in 12.5-mg, 25-mg, 50-mg, and 100-mg dosages. The safety and efficacy of milnacipran HCI, a selective serotonin and norepinephrine dual reuptake inhibitor, was established…
Read >

  Researchers Determine Rates of Self-Medication in Mood Disorders Patient Self-medication, defined as using alcohol and/or drugs to alleviate emotional distress, is a dangerous habit for patients suffering from mood disorders. Although rates of self-medication have previously been found to be fairly high in mood disorders patients, research on this topic has been at a…
Read >

  NeuroStar TMS Therapy Approved by FDA for MDD The NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy system was approved by the United States Food and Drug Administration for the treatment of major depressive disorder (MDD). Mark George, MD, of the Medical University of South Carolina (MUSC) initiated research on the treatment. “I began researching prefrontal…
Read >